72.19.Z - Scientific research and development activities
58.14.Z - Publishing activities
72.11.Z - Scientific research and development activities
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 13,7 | 8,6 | -17,1 | -300 |
EBITDA | 21,2 | 20,5 | -1,5 | -107,5 |
Short time liabilities | 21,5 | 52,2 | 56,6 | 8,6 |
Equity capital | 4,4 | 12,7 | -4,6 | -136,4 |
Operating profit (EBIT) | 14,2 | 8,9 | -17 | -291 |
Assets | 157,9 | 200,7 | 196 | -2,3 |
Net profit (loss) | 13,5 | 8,4 | -17,3 | -307,6 |
Cash | 10,1 | 25,3 | 12,9 | -48,9 |
Liabilities and provisions for liabilities | 153,5 | 188 | 200,6 | 6,7 |
Net income from sale | 183,4 | 281,7 | 394,4 | 40 |
Working assets | 35,1 | 73,3 | 58,2 | -20,7 |
Depreciation | 7 | 11,7 | 15,4 | 32,5 |
% | % | % | p.p. | |
Profitability of capital | 310,2 | 65,7 | 375 | 309,3 |
Equity capital to total assets | 2,8 | 6,3 | -2,4 | -8,7 |
Gross profit margin | 7,5 | 3 | -4,3 | -7,3 |
EBITDA Margin | 11,6 | 7,3 | -0,4 | -7,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 43 | 68 | 52 | -16 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane